Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.7153
Peer-review started: February 17, 2022
First decision: March 24, 2022
Revised: April 4, 2022
Accepted: May 22, 2022
Article in press: May 22, 2022
Published online: July 16, 2022
It is rare for urothelial and renal cell carcinomas to coexist in the same patient, and even rarer for them to be detected simultaneously. Because of this rarity, a standard treatment has not been established and studies about overall survival are scarce. Therefore, physicians must modify treatments according to the individual’s situation and the stage of each disease. In recent years, with advances in the instruments and techniques, minimal invasive robotic surgeries have become available for advanced-stage or high-risk patients.
An 85-year-old woman with a medical history of hypertension and hyperlipidemia visited our institution. She had visited her local hospital complaining of intermittent, painless, gross hematuria that had started 3 mo earlier. On computed tomography, a right renal mass and left proximal ureteral mass with hydro
This case report assessed the feasibility of simultaneous minimal invasive robotic surgery as an alternative to conventional open or laparoscopic surgery.
Core Tip: Upper tract urothelial carcinoma with synchronous contralateral renal cell carcinoma is extremely rare and seldom reported. There have only been a few reported cases or a small series. Therefore, no effective standard treatment has been established. In high-risk patients with multiple comorbidities or the super elderly, a conventional open or laparoscopic approach to bilateral tumor lesions can be burdensome to both patient and surgeon, considering perioperative or postoperative complications. This case report might present an attractive treatment option using a minimal invasive robot-assisted approach done simultaneously at once, and suggests that these methods can be used more widely.